Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- Center for International Blood and Marrow Transplant Research
- Study ID
- NCT02934477
- Status
- Recruiting
Conditions
- Myelofibrosis
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Hematopoietic Stem Cell Transplant — OTHERThis observational study will compare outcomes of prospectively enrolled HCT recipients with outcomes of a cohort of age-matched non-HCT controls.
Study Details
This observational study will compare outcomes of a prospectively-enrolled cohort of Hematopoietic Stem Cell Transplant (HCT) recipients with outcomes of a cohort of age-matched historical non-HCT controls. Patients undergoing alloHCT will receive HCT in a US transplant center and be reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) using well-established CIBMTR report forms and data collection procedures as well as a study-specific supplemental form. Data on the historical non-HCT controls will be collected at 14 US academic centers. These centers will provide data on all consecutive patients with PMF, post-ET MF, or post-PV MF referred to their institutions between 2000 and 2012.
Key Dates
- Start date
- Nov 30, 2016
- Status verified
- Aug 2023
- Primary completion
- Nov 30, 2026
- Completion
- Oct 31, 2027
Study Design
- Enrollment
- 650 participants (estimated)
Arms
- Arm: Hematopoietic Stem Cell Transplant (HCT)Patients undergoing alloHCT in a US transplant center and reported to the CIBMTR
- Arm: Non-HCTHistorical non-transplant controls collected from 14 US academic centers. Centers will provide data on all consecutive patients with PMF, post-ET MF, or post-PV MF referred to their institutions between 2000 and 2012.
Primary Outcome Measure
Compare five year survival [ Time Frame: Five years post transplant ]
Central Contacts
- Patricia Steinert, PhD414-805-0700
- Stephanie Farnia763-406-8640
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center for International Blood and Marrow Transplant Research | Minneapolis | Minnesota | 55401 | Michael Tierney |
Find similar trials in Minneapolis, MN
Related Studies
- Myeloablative Allo HSCT With Related or Unrelated Donor for Heme DisordersPHASE2 · Recruiting · Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Study of Oral Nuvisertib (TP-3654) in Patients With MyelofibrosisPHASE1/PHASE2 · Recruiting · Sumitomo Pharma America, Inc. · Birmingham, Alabama
- Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaPHASE1/PHASE2 · Recruiting · Disc Medicine, Inc · Duarte, California